"Discontinuation of Popular Asthma Inhaler Raises Concerns for Patients and Providers"
Parents across the United States have been facing difficulties in obtaining a common asthma medication for their children due to changes in drug pricing. The medication, previously covered by insurance, is now not only uncovered but also at risk of being completely removed from the market. This situation has left many families in a challenging position to manage their children's asthma care.